|
|
||||||||
induces systolic cardiac failure marked by exhausted inotropic reserve and intact Frank-Starling mechanism
Center for Cardiovascular Research, 1Department of Medicine, Section of Cardiology, and 2Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, Chicago, Illinois
Submitted 5 May 2005 ; accepted in final form 8 June 2005
Myofilament dysfunction is a common point of convergence for many forms of heart failure. Recently, we showed that cardiac overexpression of PKC
initially depresses myofilament activity and then leads to a progression of changes characteristic of human heart failure. Here, we examined the effects of PKC
on contractile reserve, Starling mechanism, and myofilament activation in this model of end-stage dilated cardiomyopathy. Pressure-volume loop analysis and echocardiography showed that the PKC
mice have markedly compromised systolic function and increased end-diastolic volumes. Dobutamine challenge resulted in a small increase in contractility in PKC
mice but failed to enhance cardiac output. The PKC
mice showed a normal length-dependent tension development in skinned cardiac muscle preparations, although Frank-Starling mechanism appeared to be compromised in the intact animal. Simultaneous measurement of tension and ATPase demonstrated that the maximum tension and ATPase were markedly lower in the PKC
mice at any length or Ca2+ concentration. However, the tension cost was also lower indicating less energy expenditure. We conclude 1) that prolonged overexpression of PKC
ultimately leads to a dilated cardiomyopathy marked by exhausted contractile reserve, 2) that PKC
does not compromise the Frank-Starling mechanism at the myofilament level, and 3) that the Starling curve excursion is limited by the inotropic state of the heart. These results reflect the significance of the primary myofilament contractilopathy induced by phosphorylation and imply a role for PKC
-mediated phosphorylation in myofilament physiology and the pathophysiology of decompensated cardiac failure.
pressure-volume loops; cardiac myofilaments
This article has been cited by other articles:
![]() |
T. Koyanagi, L. Y. Wong, K. Inagaki, O. V. Petrauskene, and D. Mochly-Rosen Alteration of gene expression during progression of hypertension-induced cardiac dysfunction in rats Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H220 - H226. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Hankiewicz, P. H. Goldspink, P. M. Buttrick, and E. D. Lewandowski Principal strain changes precede ventricular wall thinning during transition to heart failure in a mouse model of dilated cardiomyopathy Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H330 - H336. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Belin, M. P. Sumandea, E. J. Allen, K. Schoenfelt, H. Wang, R. J. Solaro, and P. P. de Tombe Augmented Protein Kinase C-{alpha}-Induced Myofilament Protein Phosphorylation Contributes to Myofilament Dysfunction in Experimental Congestive Heart Failure Circ. Res., July 20, 2007; 101(2): 195 - 204. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |